Predictive Oncology Inc., a biotechnology firm based in Pittsburgh, PA, has successfully completed a $413,000 equity fundraising round, as reported in its SEC Form D filing dated September 8, 2025. The offering, which was fully subscribed by a single investor, reflects the company's ongoing efforts to advance its innovative solutions in the healthcare sector.
Related articles
Press ReleaseMay 25, 2026
FinVolution Group Announces New Share Repurchase Program of Up to US$150 million
May 25, 2026
Press ReleaseMay 25, 2026
TECO Signs Acquisition Agreement with Malaysia's Dynaciate, Targeting Exponential AIDC Revenue Growth Next Year
May 25, 2026
Press ReleaseMay 25, 2026
Cyient Semiconductors Announces Strategic Financing with Edelweiss at ~ USD 500 Mn. Equity Valuation
May 25, 2026
← Back to all articles
Generated by Olivia 6